Keeren Rameshchandra Shah
Chief Financial Officer · OKYO Pharma Ltd
Individual
- 2026
- Jun 10, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Keeren Rameshchandra Shah files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gabriele M. Cerrone - $35K in OKYO purchases and sales in the last 12 months
- Flavio Mantelli - $28K in OKYO purchases and sales in the last 12 months
- Robert John Dempsey - $23K in OKYO purchases and sales in the last 12 months
- John P. Brancaccio - $7K in OKYO purchases and sales in the last 12 months
- Rajkumar V. Patil - $5K in OKYO purchases and sales in the last 12 months
- Gary S. Jacob - $5K in OKYO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Keeren Rameshchandra Shah?
Keeren Rameshchandra Shah is a corporate insider, tracked as Chief Financial Officer of OKYO Pharma Ltd (OKYO). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Keeren Rameshchandra Shah last file a Form 4?
The only primary Form 4 on record is dated 10 June 2026.